SCHEMBL31331962

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	10/20	0.57

▸	KEAP1	Q14145	2/20	0.56

▸	PTH1R	Q03431	3/20	0.55

▸	CALCR	P30988	3/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29973140	0.90	CALCR (0.61)	GLP1RPTH1RCALCR
SCHEMBL31182893	0.89	PTH1R (0.67)	GLP1RKEAP1PTH1RCALCR
SCHEMBL29565282	0.88	GLP1R (0.60)	GLP1RPTH1RCALCR
SCHEMBL30658269	0.88	CALCR (0.68)	GLP1RKEAP1PTH1RCALCR
SCHEMBL30423068	0.87	GLP1R (0.59)	GLP1RKEAP1
SCHEMBL29973471	0.87	GLP1R (0.60)	GLP1R
SCHEMBL29973282	0.87	EDNRA (0.56)	GLP1R
SCHEMBL30176481	0.87	GLP1R (0.59)	GLP1R
SCHEMBL31182479	0.87	GLP1R (0.57)	GLP1RKEAP1PTH1RCALCR
SCHEMBL31376429	0.86	PTH1R (0.60)	GLP1RPTH1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	GLP1R 13/4885KEAP1 3945/4885PTH1R 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.